Michael R Pranzatelli
Affiliations: | Neurology | University of Central Florida, Orlando, FL, United States |
Google:
"Michael Pranzatelli"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pranzatelli MR, Tate ED, McGee NR, et al. (2018) Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome. Pediatric Neurology |
| Pranzatelli MR, Tate ED, McGee NR. (2018) Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children. Pediatric Blood & Cancer. e27097 |
| Pranzatelli MR, McGee NR, Tate ED. (2018) Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS. Journal of Neuroimmunology |
| Pranzatelli MR, Allison TJ, Tate ED. (2018) Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society |
| Pranzatelli MR, Allison TJ, McGee NR, et al. (2018) Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and non-inflammatory neurologic disorders. Clinical and Experimental Immunology |
| Pranzatelli MR, McGee NR. (2018) Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e433 |
| Pranzatelli MR, Tate ED. (2018) Corrigendum to "Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome" [Pediatric Neurology 73 (2017) 48-56]. Pediatric Neurology. 78: 84 |
| Pranzatelli MR, Tate ED, Alber M, et al. (2017) Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations. Neuropediatrics |
| Bielekova B, Pranzatelli MR. (2017) Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping. Seminars in Pediatric Neurology. 24: 229-239 |
| Pranzatelli MR, Tate ED, McGee NR. (2017) Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges. Journal of the Neurological Sciences. 381: 285-290 |